STAT3 is a central regulator of lymphocyte differentiation and function

Current Opinion in Immunology

Volumn 28, Issue 1, 2014, Pages 49-57

  Kane, Alisa ^a,b   Deenick, Elissa K ^a,b   Ma, Cindy S ^a,b   Cook, Matthew C ^c,d   Uzel, Gulbu ^e   Tangye, Stuart G ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Biology and Environment   (Australia)

^d CANBERRA HOSPITAL   (Australia)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; STAT3 PROTEIN;

ANTIGEN SPECIFICITY; AUTOSOMAL DOMINANT DISORDER; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; GENE MUTATION; HUMAN; HYPER IGE SYNDROME; IMMUNE DEFICIENCY; IMMUNOREGULATION; LEUKOCYTE FUNCTION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PLASMA CELL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TFH CELL; TH17 CELL; TH2 CELL;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; JOB SYNDROME; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; STAT3 TRANSCRIPTION FACTOR;

EID: 84896881838     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.01.015     Document Type: Review

References (59)

1. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002, 3:651-662.
2. Shuai K., Liu B. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 2003, 3:900-911.
3. O'Shea J.J., Holland S.M., Staudt L.M. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013, 368:161-170.
4. Al-Herz W., Bousfiha A., Casanova J.L., Chapel H., Conley M.E., Cunningham-Rundles C., Etzioni A., Fischer A., Franco J.L., Geha R.S., et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011, 2:54.
5. Casanova J.L., Holland S.M., Notarangelo L.D. Inborn errors of human JAKs and STATs. Immunity 2012, 36:515-528.
6. Milner J.D., Holland S.M. The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol 2013, 13:635-648.
7. Davis S.D., Schaller J., Wedgwood R.J. Job's syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet 1966, 1:1013-1015.
8. Buckley R.H., Wray B.B., Belmaker E.Z. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972, 49:59-70.
9. Freeman A.F., Holland S.M. The hyper-IgE syndromes. Immunol Allergy Clin North Am 2008, 28:277-291. viii.
10. Grimbacher B., Holland S.M., Puck J.M. Hyper-IgE syndromes. Immunol Rev 2005, 203:244-250.
11. Chandesris M.O., Melki I., Natividad A., Puel A., Fieschi C., Yun L., Thumerelle C., Oksenhendler E., Boutboul D., Thomas C., et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine 2012, 91:e1-e19.
12. Siegel A.M., Heimall J., Freeman A.F., Hsu A.P., Brittain E., Brenchley J.M., Douek D.C., Fahle G.H., Cohen J.I., Holland S.M., et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011, 35:806-818.
13. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007, 357:1608-1619.
14. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
15. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997, 94:3801-3804.
16. Deenick E.K., Ma C.S., Brink R., Tangye S.G. Regulation of T follicular helper cell formation and function by antigen presenting cells. Curr Opin Immunol 2011, 23:111-118.
17. + T cells. Science 2010, 327:1098-1102.
18. Yamane H., Paul W.E. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev 2013, 252:12-23.
19. Harris T.J., Grosso J.F., Yen H.R., Xin H., Kortylewski M., Albesiano E., Hipkiss E.L., Getnet D., Goldberg M.V., Maris C.H., et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007, 179:4313-4317.
20. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
21. Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., Dong C. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007, 282:9358-9363.
22. Nishihara M., Ogura H., Ueda N., Tsuruoka M., Kitabayashi C., Tsuji F., Aono H., Ishihara K., Huseby E., Betz U.A., et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 2007, 19:695-702.
23. Ma C.S., Chew G.Y., Simpson N., Priyadarshi A., Wong M., Grimbacher B., Fulcher D.A., Tangye S.G., Cook M.C. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008, 205:1551-1557.
24. de Beaucoudrey L., Puel A., Filipe-Santos O., Cobat A., Ghandil P., Chrabieh M., Feinberg J., von Bernuth H., Samarina A., Janniere L., et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008, 205:1543-1550.
25. Renner E.D., Rylaarsdam S., Anover-Sombke S., Rack A.L., Reichenbach J., Carey J.C., Zhu Q., Jansson A.F., Barboza J., Schimke L.F., et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 2008, 122:181-187.
26. Cypowyj S., Picard C., Marodi L., Casanova J.L., Puel A. Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol 2012, 42:2246-2254.
27. Kotlarz D., Zietara N., Uzel G., Weidemann T., Braun C.J., Diestelhorst J., Krawitz P.M., Robinson P.N., Hecht J., Puchalka J., et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med 2013, 210:433-443.
28. Wei L., Laurence A., Elias K.M., O'Shea J.J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007, 282:34605-34610.
29. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., O'Shea J.J. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A 2006, 103:8137-8142.
30. Durant L., Watford W.T., Ramos H.L., Laurence A., Vahedi G., Wei L., Takahashi H., Sun H.W., Kanno Y., Powrie F., et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010, 32:605-615.
31. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
32. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., Ma L., Shah B., Panopoulos A.D., Schluns K.S., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
33. Stritesky G.L., Muthukrishnan R., Sehra S., Goswami R., Pham D., Travers J., Nguyen E.T., Levy D.E., Kaplan M.H. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 2011, 34:39-49.
34. Ma C.S., Avery D.T., Chan A., Batten M., Bustamante J., Boisson-Dupuis S., Arkwright P.D., Kreins A.Y., Averbuch D., Engelhard D., et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 2012, 119:3997-4008.
35. Xu L., Kitani A., Stuelten C., McGrady G., Fuss I., Strober W. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 2010, 33:313-325.
36. Chaudhry A., Rudra D., Treuting P., Samstein R.M., Liang Y., Kas A., Rudensky A.Y. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326:986-991.
37. Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., Tsuge I., et al. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 2011, 208:235-249.
38. Tangye S.G., Ma C.S., Brink R., Deenick E.K. The good, the bad and the ugly-TFH cells in human health and disease. Nat Rev Immunol 2013, 13:412-426.
39. Mazerolles F., Picard C., Kracker S., Fischer A., Durandy A. Blood CD4+CD45RO+CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency. J Allergy Clin Immunol 2013, 131:1146-1156. 1156 e1141-1145.
40. Deenick E.K., Avery D.T., Chan A., Berglund L.J., Ives M.L., Moens L., Stoddard J.L., Bustamante J., Boisson-Dupuis S., Tsumura M., et al. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J Exp Med 2013, 210:2739-2753.
41. Batten M., Ramamoorthi N., Kljavin N.M., Ma C.S., Cox J.H., Dengler H.S., Danilenko D.M., Caplazi P., Wong M., Fulcher D.A., et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med 2010, 207:2895-2906.
42. Nurieva R.I., Chung Y., Hwang D., Yang X.O., Kang H.S., Ma L., Wang Y.H., Watowich S.S., Jetten A.M., Tian Q., et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008, 29:138-149.
43. Choi Y.S., Eto D., Yang J.A., Lao C., Crotty S. Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation. J Immunol 2013, 190:3049-3053.
44. Leung D.Y., Ambrosino D.M., Arbeit R.D., Newton J.L., Geha R.S. Impaired antibody responses in the hyperimmunoglobulin E syndrome. J Allergy Clin Immunol 1988, 81:1082-1087.
45. Sheerin K.A., Buckley R.H. Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol 1991, 87:803-811.
46. Dreskin S.C., Goldsmith P.K., Gallin J.I. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A. J Clin Invest 1985, 75:26-34.
47. Avery D.T., Deenick E.K., Ma C.S., Suryani S., Simpson N., Chew G.Y., Chan T.D., Palendira U., Bustamante J., Boisson-Dupuis S., et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010, 207:155-171.
48. Meyer-Bahlburg A., Renner E.D., Rylaarsdam S., Reichenbach J., Schimke L.F., Marks A., Tcheurekdjian H., Hostoffer R., Brahmandam A., Torgerson T.R., et al. Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. J Allergy Clin Immunol 2012, 129:559-562. 562 e551-552.
49. Fornek J.L., Tygrett L.T., Waldschmidt T.J., Poli V., Rickert R.C., Kansas G.S. Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood 2006, 107:1085-1091.
50. Ettinger R., Sims G.P., Fairhurst A.M., Robbins R., da Silva Y.S., Spolski R., Leonard W.J., Lipsky P.E. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 2005, 175:7867-7879.
51. Diehl S.A., Schmidlin H., Nagasawa M., van Haren S.D., Kwakkenbos M.J., Yasuda E., Beaumont T., Scheeren F.A., Spits H. STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol 2008, 180:4805-4815.
52. Berglund L.J., Avery D.T., Ma C.S., Moens L., Deenick E.K., Bustamante J., Boisson-Dupuis S., Wong M., Adelstein S., Arkwright P.D., et al. IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts. Blood 2013, 122:3940-3950.
53. Ives M.L., Ma C.S., Palendira U., Chan A., Bustamante J., Boisson-Dupuis S., Arkwright P.D., Engelhard D., Averbuch D., Magdorf K., et al. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function. J Allergy Clin Immunol 2013, 132:400-411. e409.
54. Cui W., Liu Y., Weinstein J.S., Craft J., Kaech S.M. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 2011, 35:792-805.
55. Johnson L.D., Jameson S.C. Immunology. A chronic need for IL-21. Science 2009, 324:1525-1526.
56. Caccamo N., La Mendola C., Orlando V., Meraviglia S., Todaro M., Stassi G., Sireci G., Fournie J.J., Dieli F. Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood 2011, 118:129-138.
57. Ness-Schwickerath K.J., Jin C., Morita C.T. Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. J Immunol 2010, 184:7268-7280.
58. Cho J.S., Pietras E.M., Garcia N.C., Ramos R.I., Farzam D.M., Monroe H.R., Magorien J.E., Blauvelt A., Kolls J.K., Cheung A.L., et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010, 120:1762-1773.
59. Taylor P.R., Roy S., Leal S.M., Sun Y., Howell S.J., Cobb B.A., Li X., Pearlman E. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat Immunol 2013, (15):143-151.